{"id":"https://openalex.org/W4283575436","doi":"https://doi.org/10.1136/annrheumdis-2022-eular.209","title":"OP0023 A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING SECUKINUMAB 300 MG AND 150 MG AT WEEK 52 IN PATIENTS WITH ANKYLOSING SPONDYLITIS WHO DID NOT ACHIEVE INACTIVE DISEASE DURING AN INITIAL 16 WEEKS OF OPEN-LABEL TREATMENT WITH SECUKINUMAB 150 MG","display_name":"OP0023 A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING SECUKINUMAB 300 MG AND 150 MG AT WEEK 52 IN PATIENTS WITH ANKYLOSING SPONDYLITIS WHO DID NOT ACHIEVE INACTIVE DISEASE DURING AN INITIAL 16 WEEKS OF OPEN-LABEL TREATMENT WITH SECUKINUMAB 150 MG","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283575436","doi":"https://doi.org/10.1136/annrheumdis-2022-eular.209"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2022-eular.209","doi":"https://doi.org/10.1136/annrheumdis-2022-eular.209","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2022-eular.209","pdf_url":"https://ard.bmj.com/content/annrheumdis/81/Suppl_1/16.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ard.bmj.com/content/annrheumdis/81/Suppl_1/16.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111888136","display_name":"Atul A. Deodhar","orcid":"https://orcid.org/0000-0002-2130-1246","observed_orcids":["https://orcid.org/0000-0002-2130-1246"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Deodhar","raw_affiliation_strings":["Oregon Health & Science University, Rheumatology, Portland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University, Rheumatology, Portland, United States of America","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061842018","display_name":"A. Kivitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112965","display_name":"Altoona Center for Clinical Research","ror":"https://ror.org/022q8ez38","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210112965"]},{"id":"https://openalex.org/I4210160432","display_name":"Altoona Arthritis and Osteoporosis Center","ror":"https://ror.org/05y09kt11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Kivitz","raw_affiliation_strings":["Altoona Center for Clinical Research, Altoona Arthritis and Osteoporosis Center, Duncansville, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Altoona Center for Clinical Research, Altoona Arthritis and Osteoporosis Center, Duncansville, United States of America","institution_ids":["https://openalex.org/I4210112965","https://openalex.org/I4210160432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070521166","display_name":"M. Magrey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Magrey","raw_affiliation_strings":["University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Rheumatology, Cleveland, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Rheumatology, Cleveland, United States of America","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041680549","display_name":"J.A. Walsh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I4210095710","display_name":"Lake City VA Medical Center","ror":"https://ror.org/00nvney28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210095710","https://openalex.org/I4210118777","https://openalex.org/I4210119004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.A. Walsh","raw_affiliation_strings":["University of Utah School of Medicine and Salt Lake City Veterans Affairs Medical Center, Rheumatology, Salt Lake City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Utah School of Medicine and Salt Lake City Veterans Affairs Medical Center, Rheumatology, Salt Lake City, United States of America","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I4210095710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081778211","display_name":"Philip J. Mease","orcid":"https://orcid.org/0000-0002-6620-0457","observed_orcids":["https://orcid.org/0000-0002-6620-0457"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210093417","display_name":"Swedish Medical Center","ror":"https://ror.org/004jktf35","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210093417","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P.J. Mease","raw_affiliation_strings":["Swedish Medical Center/Providence St. Joseph Health and University of Washington, Rheumatology, Seattle, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Swedish Medical Center/Providence St. Joseph Health and University of Washington, Rheumatology, Seattle, United States of America","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210093417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087929986","display_name":"M. Greenwald","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Greenwald","raw_affiliation_strings":["Desert Medical Advances, Rheumatology, Palm Desert, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Desert Medical Advances, Rheumatology, Palm Desert, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039741553","display_name":"R. Calheiros","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Calheiros","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, Rheumatology, East Hanover, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, Rheumatology, East Hanover, United States of America","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078158480","display_name":"Farid Kianifard","orcid":"https://orcid.org/0000-0002-8472-2902","observed_orcids":["https://orcid.org/0000-0002-8472-2902"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Kianifard","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, Biostatistics, East Hanover, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, Biostatistics, East Hanover, United States of America","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037193501","display_name":"C. Elam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Elam","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, Clinical Research, East Hanover, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, Clinical Research, East Hanover, United States of America","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036053593","display_name":"K. Nagar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090302","display_name":"Novartis (India)","ror":"https://ror.org/00dhvr506","country_code":"IN","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210090302"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"K. Nagar","raw_affiliation_strings":["Novartis Healthcare Pvt Ltd, Biostatistics, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Healthcare Pvt Ltd, Biostatistics, Hyderabad, India","institution_ids":["https://openalex.org/I4210090302"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014343901","display_name":"Adam Winseck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Winseck","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, Rheumatology, East Hanover, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, Rheumatology, East Hanover, United States of America","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010216635","display_name":"L. S. Gensler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L.S. Gensler","raw_affiliation_strings":["University of California, San Francisco, Department of Medicine, San Francisco, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, Department of Medicine, San Francisco, United States of America","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":null,"first_page":"16","last_page":"17"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11571","display_name":"Sarcoidosis and Beryllium Toxicity Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ankylosing-spondylitis","display_name":"ankylosing spondylitis","score":0.9739999771118164},{"id":"https://openalex.org/keywords/secukinumab","display_name":"secukinumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.9010000228881836},{"id":"https://openalex.org/keywords/inadequate-treatment-response","display_name":"inadequate response","score":0.5770000219345093},{"id":"https://openalex.org/keywords/inactive-disease","display_name":"inactive disease","score":0.734000027179718},{"id":"https://openalex.org/keywords/asdas","display_name":"ASDAS","score":0.7419999837875366},{"id":"https://openalex.org/keywords/bath-ankylosing-spondylitis-disease-activity-index","display_name":"BASDAI","score":0.9309999942779541},{"id":"https://openalex.org/keywords/asas","display_name":"ASAS","score":0.5690000057220459},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.6000000238418579},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8379999995231628},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.33399999141693115},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.367000013589859}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9631820917129517},{"id":"https://openalex.org/C2777402515","wikidata":"https://www.wikidata.org/wiki/Q52849","display_name":"Ankylosing spondylitis","level":2,"score":0.8856492042541504},{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.8082666397094727},{"id":"https://openalex.org/C2777453003","wikidata":"https://www.wikidata.org/wiki/Q4834648","display_name":"BASDAI","level":4,"score":0.7624895572662354},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6384987831115723},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5861994624137878},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5063177347183228},{"id":"https://openalex.org/C2779650986","wikidata":"https://www.wikidata.org/wiki/Q2165411","display_name":"Spondylitis","level":3,"score":0.4376831352710724},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.400846928358078},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2871544361114502},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.0969315767288208}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/annrheumdis-2022-eular.209","doi":"https://doi.org/10.1136/annrheumdis-2022-eular.209","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2022-eular.209","pdf_url":"https://ard.bmj.com/content/annrheumdis/81/Suppl_1/16.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2022-eular.209","doi":"https://doi.org/10.1136/annrheumdis-2022-eular.209","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2022-eular.209","pdf_url":"https://ard.bmj.com/content/annrheumdis/81/Suppl_1/16.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1331633265","display_name":null,"funder_award_id":"OCAY-18-774_OFIL","funder_id":"https://openalex.org/F4320306460","funder_display_name":"Oak Foundation"},{"id":"https://openalex.org/G4112386259","display_name":null,"funder_award_id":"OCAY-18-774-OFIL","funder_id":"https://openalex.org/F4320315119","funder_display_name":"Parker Institute for Cancer Immunotherapy"}],"funders":[{"id":"https://openalex.org/F4320306460","display_name":"Oak Foundation","ror":"https://ror.org/006ss0h52"},{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320315119","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02"},{"id":"https://openalex.org/F4320325957","display_name":"Novo Nordisk Fonden","ror":"https://ror.org/04txyc737"},{"id":"https://openalex.org/F4320325987","display_name":"Galderma","ror":"https://ror.org/05fswdm20"},{"id":"https://openalex.org/F4320327470","display_name":"Swedish Orphan Biovitrum","ror":"https://ror.org/04asvbz37"},{"id":"https://openalex.org/F4320328070","display_name":"Sun Pharma","ror":"https://ror.org/04vnqkx80"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283575436.pdf","grobid_xml":"https://content.openalex.org/works/W4283575436.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4401526042","https://openalex.org/W2951597704","https://openalex.org/W2412485283","https://openalex.org/W3002825154","https://openalex.org/W2780640950","https://openalex.org/W2947144554","https://openalex.org/W4246768022","https://openalex.org/W2417531903","https://openalex.org/W4297037057","https://openalex.org/W2752880836"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-28T00:00:00"}